Previous Page  14 / 15 Next Page
Information
Show Menu
Previous Page 14 / 15 Next Page
Page Background

Page 64

Pharmaceutica Analytica Acta | Volume: 09

September 20-22, 2018 Prague, Czech Republic

Pharmaceutics & Drug Delivery Systems

17

th

Annual Congress on

Baicalein attenuates LPS-induced oxidative stress and inflammation, might be via CaMKII inhibition

Mary X Zhang

1

, Jiming Ye

1

, Dominic Ng

2

, Ross Vlahos

1

, Steve Bozinovski

1

, Jun Xu

3

and

Charlie C Xue

1

1

RMIT University, Australia

2

University of Queensland, Australia

3

Sun Yat-Sen University, China

O

xidative stress and inflammation are two major contributing factors to most chronic diseases including cancer, diabetes,

cardiovascular, neurological and pulmonary diseases. Baicalein, a flavonoid bioactive compound from Scutellaria baicalensis

Georgi (also known Scutellaria Radix orHuangQin), has demonstrated antioxidant and anti-inflammatory potentials. However, the in-

depth mechanistic studies on this compound with protective effects remain to be discovered. This study on lipopolysaccharide (LPS)-

induced reactive oxygen species (ROS) in macrophages showed that pre-treatment with baicalein significantly attenuated oxidative

stress by reducing the ROS levels in a dose-dependent manner (0.1 µM, 0.33 µM, 1 µM, 3.3 µM and 10 µM). The antioxidant effects of

baicalein were 100 times stronger than N-Acetylcysteine (NAC), a commercial antioxidant agent. Furthermore, the antioxidant effects

of baicalein showed the same inhibitory pattern with KN-93, a specific inhibitor of CaMKII, in the LPS-induced ROS production

in vitro. Moreover, pre-treatment of baicalein also significantly decreases LPS-induced inflammation in macrophages by reducing

the pro-inflammatory mediators, including IL-6, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein

-1(MIP-1), regulated on activation in normal T-cell expressed and secreted (RANTES) and tumor necrosis factor (TNF α) in a

dose-dependent manner as well. We are currently identifying if CaMKII (Ca

2+

/calmodulin-dependent protein kinase II) would be a

potential primary target by baicalein with utilizing small-molecule affinity purification, and if the decreased oxidative stress which

could lead to the reduced inflammation by baicalein’s inhibition of CaMKII involves the attenuation of p38MAPK and JNK signaling

pathway for LPS-induced cytokine production by macrophage.

mary.zhang@rmit.edu.au

Pharm Anal Acta 2018, Volume: 9

DOI: 10.4172/2153-2435-C2-037